Fall 2022-MSKCC-Immuno-Oncology for the Translational Researcher Short Course (ITRSC)
Topic outline
-
-
Checkpoint Blockade-Dr. Jedd Wolchok File
-
Agonist Antibodies-Dr. Neil Segal File
-
Tumor vaccines/viruses-Dr. Dmitriy Zamarin File
-
Microbiome/tumors-Dr. Gretchen Diehl File
-
Translational Opportunities in Immunotherapy Research-Dr. Taha Merghoub File
-
Single cell analysis in Immunotherapy-Dr. Dana Pe'er File
-
Bone Marrow Transplantation-Dr. Marcel van den Brink File
-
Adoptive T cell approaches-Dr. Michel Sadelain File
-
Workshop on Flow Cytometry-Dr. Rui Gardner (Fortessa Analyzer Video) File
-
Workshop on Flow Cytometry-Dr. Rui Gardner (Cytek Aurora Video) File
-
Workshop on Flow Cytometry-Dr. Rui Gardner (Flow Cytometry Video) File
-
Workshop on Flow Cytometry-Dr. Rui Gardner (Aria Cell Sorter Video) File
-
Workshop on Flow Cytometry-Dr. Rui Gardner (SLIDES) File
-
Workshop on Immune Monitoring-Dr. Phil Wong File
-
Clinical Trial Design and Statistical Consideration in the Development of IO-Dr. Katherine Panageas File
-
Radiographic Endpoints for Immunotherapy Clinical Trial Design -Dr. Michael Postow File
-
Integrating Radiation Oncology into IO treatment-Dr. Christopher Barker File
-
Investigating immunotherapy in underserved populations-Dr. Devika Jutagir File
Fall 2022-MSKCC-Immuno-Oncology for the Translational Researcher Short Course (ITRSC)
The Memorial Sloan Kettering Cancer Center (MSKCC) Immuno-oncology for the Translational Researcher Short Course (ITRSC) is a cancer education and research experience that will enable eligible junior NCI-funded faculty to learn about tumor immunology, current immunotherapy-based clinical practice and cutting-edge translational research under the mentorship of expert MSKCC faculty. Program participants will attend an intensive 3-day virtual course, led by those centrally involved in basic and clinical immuno-oncology research. ITRSC participants will also have an opportunity to seek additional mentorship and guidance from world experts on immuno-oncology.
The objective of the ITRSC is to engage participants in an in-depth and participatory educational experience covering the topics relevant to clinical immunotherapy research and practice today: checkpoint blockade, novel immunomodulatory antibodies, cellular therapy, immune-monitoring, clinical trial design and development and points of integration with traditional cancer therapy.
